DEP: A Decentralized Large Language Model Evaluation Protocol

Jianxiang Peng, Deyi Xiong, Bojian Xiong, Juesi Xiao, Hui Guo, Shaowei Zhang, Lei Yang, Junhao Li, Zhuowen Han, Zhen Wang (72451), Siyi Hao, Chuang Liu, Yue Chen, Yuqi Ren, Ling Shi, Hairong Lyu(University of Bristol), Hongxiang Wang, Tianyu Dong

arXiv (Cornell University)

March 1, 2026

Cited by 0

Related Papers

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

|Journal of Hematology & Oncology|2022|149

Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells

|Cell Death and Disease|2013|129

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome

|Cancer Science|2021|73

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

|Annals of Hematology|2024|32

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease

|Cancer Immunology Immunotherapy|2021|22